On ECHEMI
Home > Drugs > Minocycline Hydrochloride

Minocycline Hydrochloride

Ingredients

Minocycline Hydrochloride

Name Description Content CAS NO. Manufacturer
Minocycline hydrochlorideIngredients

Extract from the above information

More
13614-98-7 15

Appearance

Its hydrochloride is commonly used, which is a yellow crystalline powder, odorless, bitter, and may deteriorate when exposed to light.

Indication

It is mainly used for rickettsial diseases, mycoplasma pneumonia, lymphogranuloma, chancre, plague, cholera, brucellosis (used in combination with streptomycin), etc. It can also be used for systemic or local infections caused by sensitive strains such as Escherichia coli, aerogenes, Shigella, Haemophilus influenzae, Klebsiella, etc. In addition, it can be used for infections caused by gonococci, syphilis, spirochetes, Listeria, Clostridium difficile, anthrax, actinomycetes, and Fusobacterium. When the patient is not resistant to penicillin, this product (or other tetracyclines) can be considered. This product can also be considered for infections caused by sensitive strains of streptococci. As for Staphylococcus aureus, most strains are resistant to this type of drug. In addition, this product can also be used for the adjuvant treatment of amebiasis. The indications are the same as those of tetracycline. It is mainly used for bacteria resistant to other tetracyclines.

Usage and Dosage

Oral. Pediatric dosage: 8 years and above, first dose: 4mg/kg, then: 2-4mg/2-4mg/(kg.time) Adult dosage: first dose: 0.2g, then 0.1g/time, once/12h Gonorrhea: 300mg, once.

Adverse Reactions

Not yet clear.

Precautions

The history of penicillin allergy should be asked. Patients with penicillin allergy should not use this medicine.

Storage

Keep in a sealed container away from light. Valid for 2 years.

Manufacturer

North China Pharmaceutical Huasheng Co., Ltd.

  • Founded in:

    1995-05-04
  • Address:

    No. 8 Yangzi Road, Shijiazhuang Economic and Technological Development Zone
  • Tax NO.:

    91130182601702614Y
  • Registered Funds:

    237.4751 million yuan
  • Email:

Other Drugs of North China Pharmaceutical Huasheng Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.